Skip to main content

Advertisement

Log in

Prebiotics, probiotics, synbiotics in surgery—are they only trendy, truly effective or even dangerous?

  • Overview
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Despite advances in surgical technique and intensive care medicine, nosocomial bacterial infections frequently occur in patients after major abdominal surgery and have a negative impact on operative outcome and hospital costs. In parallel, the routine use of antibiotics led to the development of resistance. Some probiotics (living bacteria) and prebiotics (fibers) are able to stabilize the intestinal barrier and prevent bacterial translocation and infections. The aim of this article was to review all available experience with pro- and prebiotics in surgical trials.

Materials and methods

Medical databases were searched for animal trials and randomized controlled studies with pro- and prebiotics in surgical patients. Primary endpoint of all reported studies was the occurrence of bacterial infections. In addition, type and concentration of the pro- and prebiotics, duration of therapy, adverse events, and other effects were investigated.

Results

In three animal trials and in ten of the 15 clinical studies, probiotics or synbiotics led to a significant reduction of bacterial infection rates compared to the control groups. In two studies, there was a positive trend in the groups with synbiotics, but the results were not statistically significant. Two studies showed no effect, and in one study, the mortality rate was even higher in the synbiotic group. Except in the latter study, no severe adverse events were observed. The success of treatment depends on the synbiotic preparation and the length of therapy. Patients after surgery of the liver and pancreas and multiple trauma patients profited most from synbiotic treatment.

Conclusion

The existing randomized controlled trials demonstrated a positive effect of synbiotics in patients with high-risk operations; however, synbiotic preparations should be extensively tested before using them in clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554

    Article  PubMed  Google Scholar 

  2. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D (2006) Sepsis in European intensive care units: the SOAP study. Crit Care Med 34:344–353

    Article  PubMed  Google Scholar 

  3. Barie PS, Williams MD, McCollam JS, Bates BM, Qualy RL, Lowry SF, Fry DE (2004) The PROWESS Surgical Evaluation Committee: benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis. Am J Surg 188:212–220

    Article  PubMed  CAS  Google Scholar 

  4. Wacha H, Hau T, Dittmer R, Ohmann C (1999) Risk factors associated with intraabdominal infections: a prospective multicenter study. Langenbeck`s Arch Surg 384:24–32

    Article  CAS  Google Scholar 

  5. Sawyer RG, Raymond DP, Pelletier SJ et al (2001) Implications of 2,457 consecutive surgical infections entering year 2000. Ann Surg 233:867–874

    Article  PubMed  CAS  Google Scholar 

  6. Farinas-Alvarez C, Farinas MC, Fernandez-Mazarrasa C et al (2000) Analysis of risk factors for nosocomial sepsis in surgical patients. Br J Surg 87:1076–1081

    Article  PubMed  CAS  Google Scholar 

  7. Wilson SE, Faulkner K (1998) Impact of anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections. Am Surg 64:402–407

    PubMed  CAS  Google Scholar 

  8. Rüden H, Daschner F, Schumacher M (1995) Nosokomiale Infektionen in Deutschland- Erfassung und Prävention (NIDEP Studie), Teil 1. Prävalenz nosokomialer Infektionen, Qualitätssicherung in der Krankenhaushygiene, Bd 56. Schriftenreihe des Bundesministeriums für Gesundheit. Nomos, Baden-Baden

    Google Scholar 

  9. Brook I, Frazier EH (1999) Microbiology of subphrenic abscesses: a 14-year experience. Am Surg 65:1049–1053

    PubMed  CAS  Google Scholar 

  10. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host–bacterial mutualism in the human intestine. Science 307:1915–1919

    Article  PubMed  CAS  Google Scholar 

  11. Hooper LV, Gordon JL (2001) Commensal host–bacterial relationships in the gut. Science 292:1115–1118

    Article  PubMed  CAS  Google Scholar 

  12. Guarner F, Malagelada JR (2003) Gut flora in health and disease. Lancet 361:512–519

    Article  PubMed  Google Scholar 

  13. MacFie J, Reddy BS, Gatt M, Jain PK, Sowdi R, Mitchell CJ (2006) Bacterial translocation studied in 927 patients over 13 years. Br J Surg 93(1):87–93

    Article  PubMed  CAS  Google Scholar 

  14. Nieuwenhuijs VB, Verheem A, Duijvenbode-Beumer H, Visser MR, Verhoef J, Gooszen HG, Akkermans LM (1998) The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg 228:188–93

    Article  PubMed  CAS  Google Scholar 

  15. Deitch EA, Dazhong X, Naruhn MB, Deitch DC, Qi L, Marino AA (1995) Elemental diet and iv-TPN-induced bacterial translocation is associated with loss of intestinal mucosal barrier function against bacteria. Ann Surg 221:299–307

    Article  PubMed  CAS  Google Scholar 

  16. Bengmark S (1999) Gut environment and immune function. Curr Opin Clin Nutr Metab Care 2:83–85

    Article  PubMed  CAS  Google Scholar 

  17. Seehofer D, Rayes N, Schiller R et al (2004) Probiotics partly reverse increased bacterial translocation after simultaneous liver resection and colonic anastomosis in rats. J Surg Res 117:262–271

    Article  PubMed  Google Scholar 

  18. Naaber P, Smidt I, Tamme K, Liigant A, Tapfer H, Mikelsaar M, Talvik R (2000) Translocation of indigenous microflora in an experimental model of sepsis. J Med Microbiol 49:431–439

    PubMed  CAS  Google Scholar 

  19. Runkel NSF, Moody FG, Smith GS, Rodriguez LF, LaRocco MT, Miller TA (1991) The role of the gut in the development of sepsis in acute pancreatitis. J Surg Res 51:18–23

    Article  PubMed  CAS  Google Scholar 

  20. Tran DD, Cuesta MA, van Leeuwen PA, Nauta JJ, Wesdorp RI (1993) Risk factors for multiple organ system failure and death in critically injured patients. Surgery 114:21–30

    PubMed  CAS  Google Scholar 

  21. Lane WA (1908) Results of the operative treatment of chronic constipation. Br Med J 1:126

    Article  Google Scholar 

  22. Mulder JG, Wiersma WE, Welling GW, van der Waaij D (1984) Low dose oral tobramycin treatment for selective decontamination of the digestive tract: a study in human volunteers. J Antimicrob Chemother 13(5):495–504 May

    Article  PubMed  CAS  Google Scholar 

  23. Hellinger WC, Yao JD, Alvarez S et al (2002) A randomized, prospective, double-blind evaluation of selective bowel decontamination. Tranplantation 73(12):1904–1909

    Article  Google Scholar 

  24. Zwaveling JH, Maring JK, Klompmaker IJ et al (2002) Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo-controlled trial in liver transplant recipients. Crit Care Med 30(6):1204–1209

    Article  PubMed  Google Scholar 

  25. O’May GA, Reynolds N, Smith AR, Kennedy A, Macfarlane GT (2005) Effect of pH and antibiotics on microbial overgrowth in the stomachs and duodena of patients undergoing percutaneous endoscopic gastrostomy feeding. J Clin Microbiol 43(7):3059–3065

    Article  PubMed  Google Scholar 

  26. Meyer E, Schwab F, Gastmeier P, Rueden H, Daschner FD (2006) Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004. Infection 34(6):303–309 Dec

    Article  PubMed  CAS  Google Scholar 

  27. Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC (2008) Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 46(5):668–674

    Article  PubMed  CAS  Google Scholar 

  28. Shlaes DM, Projan SJ, Edwards JE (2004) Antibiotic discovery: state of the state. ASM News 70:275–281

    Google Scholar 

  29. Schrezemeier J, de Vrese M (2001) Probiotics, prebiotics and synbiotics-approaching a definition. Am J Clin Nutr 73:361–364

    Google Scholar 

  30. Mechnikov I (1908) The prolongation of human life, 1st ed. G.P. Putnams Sons, New York.

    Google Scholar 

  31. Lin HC, Su BH, Chen AC et al (2005) Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Outcome and cost of intensive care for very low birth weight infants. Pediatrics 115(1):1–4

    PubMed  Google Scholar 

  32. D’Souza AL, Raj Cumar C, Cooke J et al (2002) Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 324(7350):1361

    Article  PubMed  Google Scholar 

  33. McCarthy J, O’Mahony L, Dunne C et al (2001) An open trial of a novel probiotic as an alternative to steroids in mild/moderately active Crohn’s disease. Gut 49(Suppl 3):A2447

    Google Scholar 

  34. Liu Q, Duan ZP, Ha da K, Bengmark S, Kurtovic J, Riordan SM (2004) Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39(5):1441–1449

    Article  PubMed  Google Scholar 

  35. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, DeSimone C, Song XY, Diehl AM (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37:343–350

    Article  PubMed  CAS  Google Scholar 

  36. Kalliomäki M, Salminen S, Arvilommi H et al (2001) Probiotics in primary prevention of atopic disease: a randomised, placebo-controlled trial. Lancet 357:1076–1079

    Article  PubMed  Google Scholar 

  37. Reid G, Charbonneau D, Erb J et al (2003) Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 35(2):131–134

    Article  PubMed  CAS  Google Scholar 

  38. Servin AL (2004) Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbial Rev 28:405–440

    Article  CAS  Google Scholar 

  39. Marco ML, Pavan S, Kleerezebem M (2006) Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol 17:204–210

    PubMed  CAS  Google Scholar 

  40. Mack DR, Michail S, Wel S et al (1999) Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276:G941–950

    PubMed  CAS  Google Scholar 

  41. Schlee M, Harder J, Köten B, Stange EF, Wehkamp J, Fellermann A (2008) Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2. Clin Exp Immunol 151(3):528–535

    Article  PubMed  CAS  Google Scholar 

  42. Bengmark S (2005) Bioecological control of the gastrointestinal tract: the role of flora and supplemented probiotics and synbiotics. Gastroenterol Clin North Am 34:413–436

    Article  PubMed  Google Scholar 

  43. Otte JM, Podolsky DK (2004) Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 286:613–626

    Article  Google Scholar 

  44. Hart AL, Lammers K, Brigidi P, Vitali B, Rizzello F, Gionchetti P, Campieri M, Kamm MA Knight SC, Stagg AJ (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53:1602–1609

    Article  PubMed  CAS  Google Scholar 

  45. Sheih YH, Chiang BL, Wang LH, Liao CK, Gill HS (2001) Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J Am Coll Nutr 20:149–156

    PubMed  CAS  Google Scholar 

  46. Niers LE, Timmermann HM, Rijkers GT, van Bleek GM, van Uden NO, Knol EF (2005) Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 35:1481–1489

    Article  PubMed  CAS  Google Scholar 

  47. Perdigon G, Nader de Macias ME, Alvarez S et al (1988) Systemic augmentation of the immune response in mice by feeding fermented milks with Lactobacillus casei and Lactobacillus acidophilus. Immunology 63:17–23

    PubMed  CAS  Google Scholar 

  48. Kaila M, Isolauri E, Soppi E et al (1992) Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain. Pediatr Res 32:141–144

    PubMed  CAS  Google Scholar 

  49. Salminen S, Bouley C, Boutron-Ruault MC et al (1998) Functional food science and gastrointestinal physiology and function. Br J Nutr 80(Suppl. 1):147–171

    Article  Google Scholar 

  50. Wang X, Andersson R, Soltesz V, Guo W, Bengmark S (1993) Water-soluble ethylhydroxy Cellulose prevents bacterial translocation induced by major liver resection in the rat. Ann Surg 217:155–167

    Article  PubMed  CAS  Google Scholar 

  51. Tsunoda A, Shibusawa M, Tsunoda Y, Watanabe M, Nomoto K, Kusano M (2002) Effect of Lactobacillus casei on a novel murine model of abdominal sepsis. J Surg Res 107(1):37–43

    PubMed  CAS  Google Scholar 

  52. Seehofer D, Rayes N, Schiller RA, Stockmann M, Müller AR, Schirmeier A, Schaeper F, Tullius SG, Bengmark S, Neuhaus P (2004) Probiotics partly reverse increased bacterial translocation after simultaneous liver resection and colonic anastomosis in the rat. J Surg Res 117:262–271

    Article  PubMed  Google Scholar 

  53. McNaught CE, Woodcock NP, MacFie J, Mitchell CJ (2002) A prospective randomised study of the probiotic Lactobacillus plantarum 299v on indices of gut barrier function in elective surgical patients. Gut 51:827–831

    Article  PubMed  CAS  Google Scholar 

  54. Anderson ADG, McNaught CE, Jain PK, MacFie J (2004) Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 53:241–245

    Article  PubMed  CAS  Google Scholar 

  55. Reddy BS, MacFie J, Gatt M, Larsen CN, Jensen SS, Leser TD (2007) Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg 94:546–554

    Article  PubMed  CAS  Google Scholar 

  56. Rayes N, Hansen S, Seehofer D et al (2002) Early enteral supply of fiber and lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 18:609–615

    Article  PubMed  Google Scholar 

  57. Pisters PWT, Hudec WA, Hess KR, Lee JE, Vauthey JN, Lahoti S, Raijman I, Evans DB (2001) Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive cases. Ann Surg 234(1):47–55

    Article  PubMed  CAS  Google Scholar 

  58. Jagannath P, Dhir V, Shrikande S, Shah RC, Mullerpatan P, Mohandas KM (2005) Effect of preoperative biliary stenting on immediate outcome after pancreatoduodenectomy. Br J Surg 92:356–361

    Article  PubMed  CAS  Google Scholar 

  59. Nomura T, Tsuchiya Y, Nashimoto A et al (2007) Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepato-Gastroenterology 54:661–663

    PubMed  Google Scholar 

  60. Rayes N, Seehofer D, Theruvath T et al (2007) Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy. Ann Surg 246:36–41

    Article  PubMed  Google Scholar 

  61. Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S (2002) Randomized clinical trial of specific Lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 89:1103–1107

    Article  PubMed  CAS  Google Scholar 

  62. Olah A, Belagyi T, Poto L, Romics L Bengmark S (2007) Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double-blind study. Hepato-Gastroenterology 54:590–594

    PubMed  Google Scholar 

  63. Besselink MGH, van Santvoort HC, Buskens E et al (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371:651–659

    Article  PubMed  Google Scholar 

  64. Shigata H, Nagino M, Kamiya J et al (2002) Bacteremia after hepatectomy: an analysis of a single-center, 10-year experience with 407 patients. Langenbeck’s Arch Surg 387:117–124

    Article  Google Scholar 

  65. Togo S, Matsuo K, Tanaka K, Matsumoto C, Shimizu T, Ueda M, Morioka D, Nagano Y, Endo I, Shimada H (2007) Perioperative infection control and its effectiveness in hepatectomy patients. J Gastroenterol Hepatol 22(11):1942–1948 Nov

    Article  PubMed  Google Scholar 

  66. Wang X, Andersson R, Soltesz V, Wang L, Bengmark S (1993) Effect of portal hypertension on bacterial translocation induced by major liver resection in rats. Eur J Surg 159:343–350

    PubMed  CAS  Google Scholar 

  67. Wang X, Guo WD, Wang Q, Andersson R, Ekblad E, Soltesz V, Bengmark S (1994) The association between enteric bacterial overgrowth and gastrointestinal motility after subtotal resection or portal vein obstruction in rats. Eur J Surg 160:153–160

    PubMed  CAS  Google Scholar 

  68. Zeuzem S (2000) Gut-liver axis. Int J Colorectal Dis 15(2):59–82

    Article  PubMed  CAS  Google Scholar 

  69. Kanazawa H, Nagino M, Kamiya S et al (2005) Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 390:104–113

    Article  PubMed  Google Scholar 

  70. Sugawara G, Nagino M, Nishio H et al (2006) Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery. A randomized controlled trial. Ann Surg 244:706–714

    Article  PubMed  Google Scholar 

  71. Rolando N, Philpott-Howard J, Williams R et al (1996) Bacterial and fungal infection in acute liver failure. Semin Liver Dis 16:389–402

    Article  PubMed  CAS  Google Scholar 

  72. Rayes N, Bechstein WO, Keck H, Blumhardt G, Lohmann R, Neuhaus P (1995) Todesursachen nach Lebertransplantation: eine Analyse von 41 Fällen bei 382 Patienten. Zentralbl Chir 120:435–438

    PubMed  CAS  Google Scholar 

  73. Hollenbaek CS, Alfrey EJ, Souba WW (2001) The effect of surgical site infection on outcomes and resource utilization after liver transplantation. Surgery 130:388–395

    Article  Google Scholar 

  74. Rayes N, Seehofer D, Hansen S, Boucsein K, Müller AR, Serke S, Bengmark S, Neuhaus P (2002) Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74(1):123–128

    Article  PubMed  Google Scholar 

  75. Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, Bengmark S, Neuhaus P (2005) Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation—a randomized, double-blind trial. Am J Transplant 5:125–130

    Article  PubMed  Google Scholar 

  76. Hammond JM, Potgieter PD, Saunders GL (1994) Selective decontamination of the digestive tract in multiple trauma patients—is there a role? Results of a prospective, double-blind, randomized trial. Crit Care Med 22(1):33–39 Jan

    PubMed  CAS  Google Scholar 

  77. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E (2006) Benefits of a synbiotic formula (Synbiotic 2000forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg 30:1848–1855

    Article  PubMed  Google Scholar 

  78. Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L (2007) Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. J Parent Enteral Nutr 31:119–126

    Article  CAS  Google Scholar 

  79. Isolauri E, Salminen S (2005) Probiotics, gut inflammation and barrier function. Gastroenterol Clin N Am 34:437–450

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nada Rayes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rayes, N., Seehofer, D. & Neuhaus, P. Prebiotics, probiotics, synbiotics in surgery—are they only trendy, truly effective or even dangerous?. Langenbecks Arch Surg 394, 547–555 (2009). https://doi.org/10.1007/s00423-008-0445-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-008-0445-9

Keywords

Navigation